News - Genmab, daratumumab

Filter

Current filters:

Genmabdaratumumab

Popular Filters

Janssen and Genmab's daratumumab fast-tracked by US FDA

03-04-2013

Denmark-based biotech firm Genmab A/S (OMX: GEN) says that the US Food and Drug Administration has granted…

BiotechnologydaratumumabGenmabJanssen BiotechJohnson & JohnsonNorth AmericaOncologyRegulation

Genmab leaps on $1.1 billion daratumumab deal with Janssen

31-08-2012

Denmark's Genmab A/S (OMX: GEN) saw its shares leap 20% to 81 Danish kroner in morning trading yesterday,…

BiotechnologydaratumumabFinancialGenmabHuMax-CD38JanssenJohnson & JohnsonLicensingOncologyPharmaceutical

More news briefs from ASH meeting

14-12-2011

In ongoing news from the American Society of Hematology (ASH) meeting taking place in San Diego, Swiss…

AmgenBiotechnologydaratumumabExjadeGenmabMerck & CoNovartisNplateOncologyPharmaceuticalResearchZolinza

Back to top